Relevium Announces DTC Eligibility for the US Market
February 08 2019 - 1:42PM
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and
Frankfurt: “6BX”) (the
“Company” or
“Relevium”) is pleased to announce it has
secured eligibility by The Depository Trust Company (DTC) for its
shares on the OTC.
DTC is a subsidiary of the Depository Trust & Clearing Corp.
that manages the electronic clearing and settlement of publicly
traded companies in the United States. DTC eligibility will
simplify the process of trading and is expected to enhance
liquidity and overall visibility in the US OTC capital markets,
where the Company trades under the symbol "RLLVF".
Aurelio Useche, CEO stated, "DTC eligibility will enable
the Company to become accessible to all US investors and
institutions, while allowing the Company's trading in the capital
markets to be strengthened."
About Relevium Technologies
Relevium is a publicly-traded company that operates in the
health and wellness industry, including legal cannabis, with a
primary focus on online distribution. The principal business of the
Company is the identification, evaluation, acquisition and
operations of brands and businesses in the Health and Wellness
markets and medical cannabis.
The Company pursues its business strategy through an acquisition
and partnership model in a holistic approach to encompass a wide
range of health and wellness consumer products. Relevium operates
through two wholly-owned subsidiaries:
BGX E-Health LLC (BGX): Based in Orlando, Florida, BGX markets
dietary supplements, nutraceuticals, sports nutrition and
cosmeceuticals primarily through its Bioganix® brand portfolio in
the US and Europe. Relevium’s brands such as Bioganix® are sold at
some of the world’s largest retailers including such as Walmart.com
and Amazon.com.
The Company’s strategy for growing its brands includes expanding
its product offering, adding new distribution channels and
developing partnerships that add value through exclusive
ingredients. BGX is currently testing a complete line of dietary
supplements derived from Cannabis with an initial focus on hemp
derived, whole plant organic extract rich in CBD (cannabidiol).
Biocannabix Health Corporation (BCX): Based in Montreal, Quebec,
BCX is an entrepreneurial venture to establish a vertically
integrated research based medical cannabis company in the
Nutraceutical space.
Cautionary Note Regarding Forward-Looking
Statements
This release includes certain statements and information that
may constitute forward-looking information within the meaning of
applicable Canadian securities laws. All statements in this news
release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives,
assumptions or expectations of future performance, including the
timing and completion of the proposed acquisitions, are
forward-looking statements and contain forward-looking information.
Generally, forward- looking statements and information can be
identified by the use of forward-looking terminology such as
“intends” or “anticipates”, or variations of such words and phrases
or statements that certain actions, events or results “may”,
“could”, “should”, “would” or “occur”. Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release. These forward-looking statements are subject
to known and unknown risks, uncertainties and other factors that
may cause the actual results, level of activity, performance or
achievements of the Company to be materially different from those
expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, the risk that
the proposed business developments may not occur as planned; the
timing and receipt of requisite approvals and failure to raise
sufficient funds.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward- looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial outlook that are
incorporated by reference herein, except in accordance with
applicable securities laws. We seek safe harbor.
On Behalf of the
Board of Directors RELEVIUM TECHNOLOGIES INC.
Aurelio UsecheChief Executive Officer |
For more
information about this press release: RELEVIUM TECHNOLOGIES
INC Tel: +1.888.528.8687Email:
investors@releviumcorp.comWebsite: www.releviumtechnologies.comLike
us on Facebook Follow us on TwitterFollow us on LinkedIn |
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024